PortfoliosLab logo

Aileron Therapeutics, Inc. (ALRN)

Equity · Currency in USD · Last updated Sep 3, 2022

Company Info

ISINUS00887A1051
CUSIP00887A105
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$0.17
Year Range$0.14 - $1.27
EMA (50)$0.24
EMA (200)$0.47
Average Volume$943.33K
Market Capitalization$15.89M

ALRNShare Price Chart


Chart placeholderClick Calculate to get results

ALRNPerformance

The chart shows the growth of $10,000 invested in Aileron Therapeutics, Inc. in Jun 2017 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $117 for a total return of roughly -98.83%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%60.00%AprilMayJuneJulyAugustSeptember
-57.45%
-8.27%
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)

ALRNReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M24.93%-4.08%
6M-59.14%-10.07%
YTD-68.93%-17.66%
1Y-84.92%-13.26%
5Y-56.96%9.65%
10Y-57.67%9.60%

ALRNMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-17.23%-8.37%19.91%-13.67%-4.52%-38.39%-26.92%-2.63%-5.46%
202175.96%-16.94%-5.92%-16.78%3.36%1.63%-17.60%11.65%-11.30%-14.71%-29.08%-8.75%
202018.36%-13.79%-43.22%64.40%196.81%-27.16%-25.42%45.45%0.78%-10.85%-5.22%-4.59%
201930.95%50.91%17.47%-11.79%-41.86%-28.00%-30.51%45.89%-8.19%-34.35%9.14%19.35%
2018-12.43%-11.05%-0.97%-37.52%1.57%5.04%-42.99%-5.50%-5.82%-14.55%-7.66%-61.29%
2017-25.67%14.80%-8.91%14.75%-10.01%-6.81%-6.06%

ALRNSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Aileron Therapeutics, Inc. Sharpe ratio is -0.96. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-1.00-0.500.000.501.00AprilMayJuneJulyAugustSeptember
-0.96
-0.64
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)

ALRNDividend History


Aileron Therapeutics, Inc. doesn't pay dividends

ALRNDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2022FebruaryMarchAprilMayJuneJulyAugustSeptember
-98.83%
-18.19%
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)

ALRNWorst Drawdowns

The table below shows the maximum drawdowns of the Aileron Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Aileron Therapeutics, Inc. is 99.07%, recorded on Aug 2, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.07%Jun 29, 20171282Aug 2, 2022

ALRNVolatility Chart

Current Aileron Therapeutics, Inc. volatility is 60.83%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


0.00%50.00%100.00%150.00%200.00%AprilMayJuneJulyAugustSeptember
60.83%
21.19%
ALRN (Aileron Therapeutics, Inc.)
Benchmark (^GSPC)